Results 211 to 220 of about 10,599,387 (354)

Macrophage‐targeted cerium‐tannic acid metal‐polyphenol framework nanoenzyme promotes in situ heart valves regeneration through adaptive immunomodulation

open access: yesBMEMat, EarlyView.
A novel nanoenzyme based on cerium ions‐tannic acid metal‐polyphenol framework (FCT) has been developed and loaded onto DHVs for targeting M1 macrophages to reduce their ROS level and reprogram macrophage phenotype, thereby eliminating inflammation, promoting endothelialization and adaptive matrix remodeling of scaffolds, offering a promising strategy ...
Peng Song   +9 more
wiley   +1 more source

Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newborn. [PDF]

open access: yesUltrasound Obstet Gynecol
van 't Oever RM   +8 more
europepmc   +1 more source

Hemolytic uremic syndrome post-diarrheal: (Week 37) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 16, 2023

open access: yes
Hemolytic uremic syndrome post-diarrheal cases. The Weekly data are considered provisional and collected locally due to state, territorial, and local regulations.

core  

Marine silicon for biomedical sustainability

open access: yesBMEMat, EarlyView.
Schematic illustrating marine silicon for biomedical engineering. Abstract Despite momentous divergence from oceanic origin, human beings and marine organisms exhibit elemental homology through silicon utilization. Notably, silicon serves as a critical constituent in multiple biomedical processes.
Yahui Han   +3 more
wiley   +1 more source

Hemolytic disease of the fetus and newborn-a perspective of immunohematology. [PDF]

open access: yesHematol Transfus Cell Ther
Rodrigues MMO   +3 more
europepmc   +1 more source

Hemolytic uremic syndrome post-diarrheal: (Week 15) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending April 15, 2023

open access: yes
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hemolytic uremic syndrome post-diarrheal cases. The Weekly data are considered provisional and collected locally due to

core  

Nano‐networks via reaction‐induced self‐assembly coordinate spatiotemporal multi‐drug delivery for acute kidney injury therapy

open access: yesBMEMat, EarlyView.
Multifunctional nano‐networks (NNWs) are prepared via reaction‐induced self‐assembly (RISA) of spermidine (SPD), epigallocatechin gallate (EGCG), 2‐formylphenylboronic acid (2‐FPBA), and deferoxamine (DFO) through dynamic iminoboronate bonds. These NNWs leverage the oxidative AKI microenvironment to trigger disintegration, enabling site‐specific ...
Juan Jin   +17 more
wiley   +1 more source

Diagnosis and management of rare congenital nonimmune hemolytic disease.

open access: yesHematology. American Society of Hematology. Education Program, 2015
P. Gallagher
semanticscholar   +1 more source

Hemolytic uremic syndrome post-diarrheal: (Week 23) Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 10, 2023

open access: yes
This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Hemolytic uremic syndrome post-diarrheal cases. The Weekly data are considered provisional and collected locally due to

core  

Eudragit®‐engineered pH‐responsive probiotic microspheres with enhanced gastrointestinal resistance and prolonged storage stability for inflammatory bowel disease therapy

open access: yesBMEMat, EarlyView.
This study reports the development of AMS@Eud core‐shell microspheres, combining calcium alginate and pH‐responsive Eudragit® L100, which exhibit exceptional gastrointestinal resistance and long‐term storage stability (only 5.28%–9.09% viability loss over 35 days at 4–25°C), and effectively alleviate inflammatory bowel disease via gut microbiota ...
Ming Teng   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy